**Core Concept:** Depression is a medical term that refers to a state of emotional downturn or sadness, which might be used to describe a range of psychiatric disorders, including major depressive disorder (MDD), which is a common mental health condition characterized by persistent feelings of sadness, loss of interest or pleasure, and changes in sleep, appetite, and energy levels. These symptoms can significantly impact an individual's daily functioning and quality of life.

**Why the Correct Answer is Right:** Depression can be caused by various factors, including medications. In this question, we are looking for a medication category that is known to cause depression as a side effect. The correct answer, option D, refers to the class of medications known as tricyclic antidepressants (TCAs). TCAs are a group of drugs that were initially developed as antihistamines and later found to have antidepressant properties. They work by blocking neurotransmitter reuptake, specifically inhibiting the reuptake of norepinephrine, serotonin, and histamine. This leads to an increase in the concentration of these neurotransmitters in the synaptic cleft, which can help alleviate symptoms of depression.

**Why Each Wrong Option is Incorrect:**

A. Monoamine oxidase inhibitors (MAOIs) are a separate class of antidepressants, and while they are also used to treat depression, they do not share the same mechanism of action as TCAs. MAOIs work by inhibiting the enzyme monoamine oxidase, which leads to an increase in the concentration of neurotransmitters like serotonin, norepinephrine, and dopamine.

B. Selective serotonin reuptake inhibitors (SSRIs) are a different class of antidepressants, primarily focused on inhibiting the reuptake of serotonin. Unlike TCAs, SSRIs do not affect the reuptake of norepinephrine and histamine.

C. Serotonin-norepinephrine reuptake inhibitors (SNRIs) are another class of antidepressants that primarily affect the reuptake of serotonin and norepinephrine. While SNRIs can also cause some degree of anticholinergic effects, they do not share the same mechanism of action as TCAs and do not affect the reuptake of histamine.

**Clinical Pearls:**

TCAs, on the other hand, are often associated with anticholinergic side effects due to their broader blockade of acetylcholine receptors. This can lead to dry mouth, blurred vision, constipation, urinary retention, and drowsiness. However, the anticholinergic side effects are not as severe as those of MAOIs and do not significantly impact the patient's quality of life.

**Why Option D is Right:**

TCAs are a broad-spectrum antidepressant that blocks the reuptake of neurotransmitters like norepinephrine, serotonin, and histamine. This broad blockade can lead to anticholinergic side effects, which are not present in the other classes of antidepressants, like SSRIs and SNRIs.

**